本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1998/5/121 分钟阅读
Pfizer, Inc.; Withdrawal of Approval of NADA's
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing approval of four new animal drug applications (NADA's) held by Pfizer, Inc. The NADA's provide for use of oxytetracycline hydrochloride. The sponsor requested the withdrawal of approval of the NADA's because the animal drug products are no longer manufactured or marketed.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →